Fibrosis Therapy
July 21, 2025
United States
6
Description
AI drug research company pioneering anti-cancer therapeutics, anti-fibrosis small molecule drugs, Smad/Smad3 inhibition, and combination cancer-fibrosis therapies Fibrosis Therapy
About Company
Moexa is an early stage multi-national drug research and development company with proprietary TGF-β/Smad3, AI designed, small molecule anti-cancer and anti-fibrosis therapeutic. Moexa's SMAD3 TGF-β prevents cancer and fibrosis.
Click Here For More Info:- https://moexa.com/
Social Media Profile Links:-
https://www.linkedin.com/company/moexa/?originalSubdomain=hk
You must log in or register a new account in order to contact the publisher
Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"